Clinical Trials in Portland

Showing 5781-5800 of 10,048 trials

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

NCT02462122

Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis

Bausch Health Americas, Inc.215 participantsStarted Aug 2015

Fremont, California, United States • Boynton Beach, Florida, United States • North Miami Beach, Florida, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy

NCT00962429

The purpose of the study is to examine if alpha lipoic acid is an effective treatment for chronic inflammatory demyelinating polyneuropathy (CIDP).

CIDPChronic Inflammatory Demyelinating Polyneuropathy

Oregon Health and Science University7 participantsStarted Feb 2009

Portland, Oregon, United States

COMPLETEDPhase 3< 1 mile

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

NCT00005970

This randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy alone in treating women with breast cancer that is human epidermal growth factor receptor 2 (HER2)-positive and has spread to the lymph nodes or high-risk and has not spread to the lymph nodes. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether combination chemotherapy is more effective with or without trastuzumab in treating breast cancer.

Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more

National Cancer Institute (NCI)3,436 participantsStarted May 2000

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +154 more locations

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Find Trials by Condition in Portland

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

The DIVERT-CARE (Collaboration Action Research & Evaluation) Trial

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Host Response Mediators in Coronavirus (COVID-19) Infection

Electrical Activation of The Diaphragm for Ventilatory Assist

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence